These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 8950143)

  • 1. Higher AUCs on oral administration of omeprazole and felodipine in Indian volunteers--are they clinically important?
    Joseph T; Gowrishankar R
    Indian J Physiol Pharmacol; 1996 Jul; 40(3):253-6. PubMed ID: 8950143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of oral omeprazole in llamas.
    Poulsen KP; Smith GW; Davis JL; Papich MG
    J Vet Pharmacol Ther; 2005 Dec; 28(6):539-43. PubMed ID: 16343286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable omeprazole kinetics in healthy Jordanian adults.
    Albsoul-Younes A; Tayyem R; Najib N
    Biopharm Drug Dispos; 2005 Jul; 26(5):183-8. PubMed ID: 15906422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of orally administered omeprazole in children. International Pediatric Omeprazole Pharmacokinetic Group.
    Andersson T; Hassall E; Lundborg P; Shepherd R; Radke M; Marcon M; Dalväg A; Martin S; Behrens R; Koletzko S; Becker M; Drouin E; Göthberg G
    Am J Gastroenterol; 2000 Nov; 95(11):3101-6. PubMed ID: 11095324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
    Frishman WH; Hainer JW; Sugg J;
    Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Itraconazole greatly increases plasma concentrations and effects of felodipine.
    Jalava KM; Olkkola KT; Neuvonen PJ
    Clin Pharmacol Ther; 1997 Apr; 61(4):410-5. PubMed ID: 9129558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bergamottin contribution to the grapefruit juice-felodipine interaction and disposition in humans.
    Goosen TC; Cillié D; Bailey DG; Yu C; He K; Hollenberg PF; Woster PM; Cohen L; Williams JA; Rheeders M; Dijkstra HP
    Clin Pharmacol Ther; 2004 Dec; 76(6):607-17. PubMed ID: 15592332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of the enantiomers of felodipine in the dog after oral and intravenous administration of a pseudoracemic mixture.
    Eriksson UG; Hoffmann KJ; Simonsson R; Regårdh CG
    Xenobiotica; 1991 Jan; 21(1):75-84. PubMed ID: 2003369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A relative bioavailability study of 2 oral formulations of omeprazole after their administration in repeated doses to healthy volunteers].
    Richards JP; Gimeno M; Moreland TA; McEwen J
    Gastroenterol Hepatol; 1999 Apr; 22(4):171-5. PubMed ID: 10349786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of omeprazole with enteric-coated salicylate tablets.
    Nefesoglu FZ; Ayanoglu-Dülger G; Ulusoy NB; Imeryüz N
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):549-53. PubMed ID: 9799060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of intravenous, plain oral and enteric-coated oral omeprazole in the horse.
    Sykes BW; Underwood C; McGowan CM; Mills PC
    J Vet Pharmacol Ther; 2015 Apr; 38(2):130-6. PubMed ID: 25271390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel option for dosing of proton pump inhibitors: dispersion of lansoprazole orally disintegrating tablet in water via oral syringe.
    Gremse DA; Donnelly JR; Kukulka MJ; Lloyd E; Lee C
    Aliment Pharmacol Ther; 2004 Jun; 19(11):1211-5. PubMed ID: 15153174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and pharmacokinetics of Logimax, a new extended-release combination tablet of felodipine and metoprolol.
    Abrahamsson B; Edgar B; Lidman K; Wingstrand K
    Blood Press Suppl; 1993; 1():10-5. PubMed ID: 8173686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability and efficacy of omeprazole given orally and by nasogastric tube.
    Larson C; Cavuto NJ; Flockhart DA; Weinberg RB
    Dig Dis Sci; 1996 Mar; 41(3):475-9. PubMed ID: 8617118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of feeding on the pharmacokinetic variables of two commercially available formulations of omeprazole.
    Sykes BW; Underwood C; McGowan CM; Mills PC
    J Vet Pharmacol Ther; 2015 Oct; 38(5):500-3. PubMed ID: 25676888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of pharmacokinetic interaction between omeprazole or lansoprazole and ivabradine in healthy volunteers: an open-label, randomized, crossover, pharmacokinetic interaction clinical trial.
    Portolés A; Calvo A; Terleira A; Laredo L; Resplandy G; Gorostiaga C; Moreno A
    J Clin Pharmacol; 2006 Oct; 46(10):1195-203. PubMed ID: 16988209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative pharmacodynamic study of IY-81149 versus omeprazole in patients with gastroesophageal reflux disease.
    Periclou AP; Goldwater R; Lee SM; Park DW; Kim DY; Cho KD; Boileau F; Jung WT
    Clin Pharmacol Ther; 2000 Sep; 68(3):304-11. PubMed ID: 11014412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differences in the release of omeprazole in 4 commercial preparations: influence of pH and ionic concentration].
    Navarro MA; Raei N; Torres F; Granero L; García-Zaragoza E; Esplugues JV; Esteban Peris J
    Gastroenterol Hepatol; 1998 Feb; 21(2):63-70. PubMed ID: 9549180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omeprazole absorption from a compounded transdermal formulation in healthy volunteers.
    Haas CE; Lin L; Cloen D; Kufel T; Moon R; Frerichs V
    J Am Pharm Assoc (2003); 2005; 45(4):473-8. PubMed ID: 16128503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of orally administered enteric-coated omeprazole on gastric acid secretion in horses.
    Andrews FM; Doherty TJ; Blackford JT; Nadeau JA; Saxton AM
    Am J Vet Res; 1999 Aug; 60(8):929-31. PubMed ID: 10451198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.